Elken Healthcare (01789) announced interim results. Profit attributable to shareholders was approximately 197 million yuan, an increase of 22.5% year-on-year

According to the Zhitong Finance App, Elken Healthcare (01789) announced its 2026 interim results, with revenue of about 765 million yuan, up 10.2% year on year; profit attributable to the company's equity shareholders was about 197 million yuan, up 22.5% year on year; profit per share was 0.1,768 yuan.

According to the announcement, revenue growth is mainly due to significant growth in overseas markets and smart device sales. The significant increase in profit is mainly due to revenue growth and the impact of higher gross margin due to higher revenue from overseas and digital orthopedic products and smart devices with relatively high gross margins.